UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038944
Receipt number R000044380
Scientific Title The multicenter, randomized control trial of outpatient rehabilitation after breast cancer surgery
Date of disclosure of the study information 2019/12/21
Last modified on 2021/09/03 20:29:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The multicenter, randomized control trial of outpatient rehabilitation after breast cancer surgery

Acronym

ORBS trial

Scientific Title

The multicenter, randomized control trial of outpatient rehabilitation after breast cancer surgery

Scientific Title:Acronym

ORBS trial

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To inspect the effectiveness of outpatient rehabilitation after breast cancer surgery

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

active shoulder ROM (range of motion) 3 months after surgery

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

1) Outpatient rehabilitation (more than 4 times during 3 months after surgery)
- Shoulder ROM exercise
- Instruction against muscle weakness, axillary web syndrome and pectoralis tightness
2) Home exercise with DVD

Interventions/Control_2

Home exercise without DVD

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

74 years-old >=

Gender

Female

Key inclusion criteria

1) >=20 and <=74 years old female
2) ECOG-PS 0-1
3) Having breast cancer surgery with axillary lymph node dissection
4) Having written informed consent

Key exclusion criteria

1) Bilateral surgery
2) Having medical history of breast cancer surgery
3) Having surgery with breast reconstruction or tissue expander insertion
4) Having metastasis before surgery
5) Having medical history of ipsilateral upper limb surgery
6) Having pain or numbness in ipsilateral upper limb before surgery
7) Having shoulder ROM restriction before surgery
8) Having upper-extremity interlimb circumference difference before surgery

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Tanuma

Organization

Juntendo University Shizuoka Hospital

Division name

Department of Rehabilitation Medicine

Zip code

410-2295

Address

1129 Nagaoka, Izunokuni-shi, Shizuoka 410-2295 JAPAN

TEL

055-948-3111

Email

a.tanuma.sy@juntendo.ac.jp


Public contact

Name of contact person

1st name Akira
Middle name
Last name Tanuma

Organization

Juntendo University Shizuoka Hospital

Division name

Department of Rehabilitation Medicine

Zip code

410-2295

Address

1129 Nagaoka, Izunokuni-shi, Shizuoka 410-2295 JAPAN

TEL

055-948-3111

Homepage URL


Email

a.tanuma.sy@juntendo.ac.jp


Sponsor or person

Institute

Department of Rehabilitation Medicine, Juntendo University Shizuoka Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shizuoka Cancer Center

Address

1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777 JAPAN

Tel

055-989-5222

Email

rinsho_office@scchr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 12 Month 06 Day

Date of IRB

2019 Year 12 Month 06 Day

Anticipated trial start date

2021 Year 08 Month 03 Day

Last follow-up date

2023 Year 11 Month 02 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 12 Month 20 Day

Last modified on

2021 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044380


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name